Singapore markets closed

Invitae Corporation (0JDB.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
0.0035+0.0032 (+1,066.67%)
At close: 04:03PM BST

Invitae Corporation

1400 16th Street
San Francisco, CA 94103
United States
415 374 7782
https://www.invitae.com

Sector(s)
Industry
Full-time employees1,700

Key executives

NameTitlePayExercisedYear born
Dr. Randal W. Scott Ph.D.Co-Founder & Chairman of the Board50kN/A1958
Mr. Kenneth D. KnightPresident, CEO & Director1.4MN/A1961
Mr. Thomas R. BridaGeneral Counsel, Chief Compliance Officer & Secretary776.72kN/A1971
Ms. Ana J. SchrankChief Accounting Officer & CFON/AN/A1966
Dr. David B. Sholehvar M.D.Chief Operating OfficerN/AN/A1968
Ms. Hoki LukHead of Investor Relations and Capital Markets & Corporate DevelopmentN/AN/A1976
Ms. Shelly D. GuyerChief Sustainability Officer430.44kN/A1960
Ms. Desarie FrenchChief Talent OfficerN/AN/AN/A
Dr. W. Michael Korn M.D.Chief Medical OfficerN/AN/AN/A
Mr. Robert GuigleyChief Commercial OfficerN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California. On February 13, 2024, Invitae Corporation, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of New Jersey.

Corporate governance

Invitae Corporation’s ISS governance QualityScore as of 1 April 2024 is 9. The pillar scores are Audit: 5; Board: 10; Shareholder rights: 7; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.